000 | 01752 a2200481 4500 | ||
---|---|---|---|
005 | 20250515095807.0 | ||
264 | 0 | _c20080422 | |
008 | 200804s 0 0 eng d | ||
022 | _a0013-7227 | ||
024 | 7 |
_a10.1210/en.2007-0656 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMontessuit, Christophe | |
245 | 0 | 0 |
_aNuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture. _h[electronic resource] |
260 |
_bEndocrinology _cMar 2008 |
||
300 |
_a1064-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAMP-Activated Protein Kinase Kinases |
650 | 0 | 4 | _aAlitretinoin |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytoskeleton _xdrug effects |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 |
_aGlucose Transporter Type 4 _xmetabolism |
650 | 0 | 4 |
_aInsulin _xphysiology |
650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrotubules _xdrug effects |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aPPAR gamma _xagonists |
650 | 0 | 4 |
_aPhenoxyacetates _xpharmacology |
650 | 0 | 4 |
_aProtein Kinases _xpharmacology |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRetinoid X Receptors _xagonists |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 |
_aTretinoin _xpharmacology |
700 | 1 | _aPapageorgiou, Irène | |
700 | 1 | _aLerch, René | |
773 | 0 |
_tEndocrinology _gvol. 149 _gno. 3 _gp. 1064-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2007-0656 _zAvailable from publisher's website |
999 |
_c17577703 _d17577703 |